Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1211843.RAO-HuG50iSfeWv0e9mJLYNITXDtnOP5YxtYMaJrW_YEs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1211843.RAO-HuG50iSfeWv0e9mJLYNITXDtnOP5YxtYMaJrW_YEs130_assertion type Assertion NP1211843.RAO-HuG50iSfeWv0e9mJLYNITXDtnOP5YxtYMaJrW_YEs130_head.
- NP1211843.RAO-HuG50iSfeWv0e9mJLYNITXDtnOP5YxtYMaJrW_YEs130_assertion description "[In this study, we show that overexpression of the oncogenic receptor tyrosine kinase AXL is sufficient to mediate acquired resistance to cetuximab in models of non-small cell lung cancer (NSCLC) and head and neck squamous cell carcinoma (HNSCC), where AXL was overexpressed, activated, and tightly associated with EGFR expression in cells resistant to cetuximab (Ctx(R) cells).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211843.RAO-HuG50iSfeWv0e9mJLYNITXDtnOP5YxtYMaJrW_YEs130_provenance.
- NP1211843.RAO-HuG50iSfeWv0e9mJLYNITXDtnOP5YxtYMaJrW_YEs130_assertion evidence source_evidence_literature NP1211843.RAO-HuG50iSfeWv0e9mJLYNITXDtnOP5YxtYMaJrW_YEs130_provenance.
- NP1211843.RAO-HuG50iSfeWv0e9mJLYNITXDtnOP5YxtYMaJrW_YEs130_assertion SIO_000772 25136066 NP1211843.RAO-HuG50iSfeWv0e9mJLYNITXDtnOP5YxtYMaJrW_YEs130_provenance.
- NP1211843.RAO-HuG50iSfeWv0e9mJLYNITXDtnOP5YxtYMaJrW_YEs130_assertion wasDerivedFrom befree-2016 NP1211843.RAO-HuG50iSfeWv0e9mJLYNITXDtnOP5YxtYMaJrW_YEs130_provenance.
- NP1211843.RAO-HuG50iSfeWv0e9mJLYNITXDtnOP5YxtYMaJrW_YEs130_assertion wasGeneratedBy ECO_0000203 NP1211843.RAO-HuG50iSfeWv0e9mJLYNITXDtnOP5YxtYMaJrW_YEs130_provenance.